ProShares UltraShort Nasdaq Biotechnology (BIS)
NASDAQ: BIS · Real-Time Price · USD
17.25
-1.00 (-5.48%)
Jan 21, 2025, 4:00 PM EST - Market closed
-5.48% (1D)
| Assets | $3.66M |
| Expense Ratio | 0.95% |
| PE Ratio | n/a |
| Shares Out | 201,096 |
| Dividend (ttm) | $0.68 |
| Dividend Yield | 3.93% |
| Ex-Dividend Date | Dec 23, 2024 |
| Payout Ratio | n/a |
| 1-Year Return | -3.69% |
| Volume | 13,012 |
| Open | 17.98 |
| Previous Close | 18.25 |
| Day's Range | 17.25 - 17.98 |
| 52-Week Low | 14.05 |
| 52-Week High | 21.10 |
| Beta | -1.14 |
| Holdings | 8 |
| Inception Date | Apr 8, 2010 |
About BIS
Fund Home PageThe ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.
Asset Class Equity
Category Trading--Inverse Equity
Stock Exchange NASDAQ
Ticker Symbol BIS
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 23, 2024 | $0.206 | n/a |
| Sep 25, 2024 | $0.152 | Oct 2, 2024 |
| Jun 26, 2024 | $0.161 | Jul 3, 2024 |
| Mar 20, 2024 | $0.159 | Mar 27, 2024 |
| Dec 20, 2023 | $0.176 | Dec 28, 2023 |
| Sep 20, 2023 | $0.119 | Sep 27, 2023 |
News
Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.
2 years ago - Seeking Alpha